Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and medicinal products for advanced therapies, and Exothera, a full-service Contract Development and Manufacturing...
read more
ReiThera, Leukocare, and Univercells announced a collaboration for the development and largescale manufacturing of a novel adenoviral vector-based vaccine against COVID-19.
read more
Wednesday, December 30, 2020
Relaxera Pharmazeutische Gesellschaft mbH & Co. KG and CBL Patras announce the signing of an exclusive contract for human relaxin-2.
read more
Wednesday, January 23, 2013
CAMO Software, leaders in multivariate data analysis solutions, today announced the release of a new version of the Unscrambler® X Process Pulse software for process monitoring. The software is designed to be used by laboratory staff, technical ...
read more
Relief and Acer announced the companies have signed an Option Agreement providing exclusivity for the right to negotiate a potential collaboration and license agreement for worldwide development and commercialization for ACER-001.
read more
Relief and NeuroRx announced NeuroRx has completed final manufacturing of intravenous RLF-100 as a potential treatment for COVID-19 ventilated patients with ARDS.
read more
Wednesday, September 26, 2018
As we all know, compounding can play an important role in patient care, but because compounded drug products are not reviewed by FDA for safety, effectiveness, or quality before they are marketed, they should be used only when necessary to meet ...
read more
Fresenius Kabi announced today the immediate availability in the United States of Remifentanil Hydrochloride for Injection.
read more
Thursday, December 14, 2017
reMYND and Novo Nordisk have entered into a license agreement to further develop reMYND's ReS39 therapeutic program of diabetes.
read more
Renaissance Acquisition Holdings, LLC (“Renaissance”), a portfolio company of RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has ...
read more
Tuesday, September 03, 2024
Renaissance Lakewood announced the official opening of their new, 67,000 sq ft, expansive warehouse at their recently opened headquarters at 1215 Paco Way in Lakewood, NJ.
read more
Wednesday, April 10, 2019
ReNeuron has signed a license agreement with Shanghai Fosun Pharmaceutical for the development, manufacture and commercialization of ReNeuron's CTX and hRPC cell therapy programs in China.
read more
RenovaCare announced its Chairman, Chief Executive Officer, and President, Alan Rubino, has decided to retire.
read more
RenovaCare has expanded its engagement with MCRA to continue to advance the Company’s FDA program.
read more
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) today provided an update on progress at Rentschler ATMP Ltd., the Company’s dedicated cell and gene therapy facility located in Stevenage, UK, including...
read more